By agreement with the publisher, this book is accessible by the search feature, but cannot be browsed.
Copyright © 1999, American Society for
Neurochemistry.
Bookshelf ID: NBK28230
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Siegel GJ, Agranoff BW, Albers RW, et al., editors. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition. Philadelphia: Lippincott-Raven; 1999.
Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition.
Show details- 1.
- Graybiel A M . Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 1990;13:244–253. [PubMed: 1695398]
- 2.
- Gerfen C R . The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 1992;15:285–320. [PubMed: 1575444]
- 3.
- Palkovits, M., and Brownstein, M. Catecholamines in the central nervous system. In U. Trendelenberg and N. Weiner (eds.), Catecholamines II. Berlin: Springer, 1989, pp. 1–26.
- 4.
- McGeer P L , McGeer S , Itagak S . et al. Anatomy and pathology of the basal ganglia. Can. J. Neurol. Sci. 1987;14:363–372. [PubMed: 2890425]
- 5.
- Fahn, S. Secondary parkinsonism. In E. S. Goldenson and S. H. Appel (eds.), Scientific Approaches to Clinical Neurology. Philadelphia: Lea & Febiger, 1977, pp. 1159–1189.
- 6.
- Carlsson A , Lindquist M , Magnusson T , Waldeck B . On the presence of 3 hydroxytyramine in brain. Science. 1958;127:471–472. [PubMed: 13529006]
- 7.
- Ehringer H , Hornykiewicz O . Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin. Wochenschr. 1960;38:1236–1239. [PubMed: 13726012]
- 8.
- Sourkes T L . On the origin of homovanillic acid in the cerebrospinal fluid. J. Neural Transm. 1973;34:153–157. [PubMed: 4722573]
- 9.
- Birkmayer W , Hornykiewicz O . Der l-3,4-dioxyphenyl-alanin (l-dopa). Effekt bei der Parkinson-Akinesia. Wien Klin. Wochenschr. 1961;73:787–788. [PubMed: 13869404]
- 10.
- Barbeau A . Dopamine and basal ganglia disease. Arch. Neurol. 1961;4:97–102. [PubMed: 13686755]
- 11.
- Birkmayer W , Mentasi M . Weitere experimentelle Untersuchungen uber den Catecholaminostoffwechsel bei extrapyramidalen Erkrankungen. Arch. Psychiatr. Nervenkr. 1967;210:29–35. [PubMed: 4292871]
- 12.
- Cotzias G C , Papavasilious P S , Gellene R . Modification of parkinsonism—chronic treatment with l-dopa. N. Engl. J. Med. 1969;280:337–345. [PubMed: 4178641]
- 13.
- Yahr M D , Duvoisin R C . Drug therapy of parkinsonism. N. Engl. J. Med. 1972;287:20–24. [PubMed: 4555145]
- 14.
- Birkmayer W , Riederer P , Youdim M B H , Linauer W . Potentiation of antikinetic effect after l-dopa treatment by an inhibitor of MAO B, l-deprenyl. J. Neural Transm. 1975;36:303–323. [PubMed: 1172524]
- 15.
- Goetz C G . Dopamine agonists in the treatment of Parkinson's disease. Neurology. 1990;40 (Suppl. 3):50–54. [PubMed: 1977104]
- 16.
- Hassler R , Riechert T . Indikationen und lokalisationsmethode der gezielten Hirnoperationen. Nervenarzt. 1954;25:441–448. [PubMed: 14356288]
- 17.
- Laiten L V , Bergenheim A T , Hariz M I . Leksell's postero-ventral pallidotomy in the treatment of Parkinson's disease. J. Neurosurg. 1992;76:53–61. [PubMed: 1727169]
- 18.
- Dostrovsky J O , Davis K D , Lee L . et al. Electrical stimulation-induced effects in the human thalamus. Adv. Neurol. 1993;63:219–229. [PubMed: 8279307]
- 19.
- Kopin I J . Features of the dopaminergic neurotoxin MPTP. Ann. N. Y. Acad. Sci. 1992;648:96–104. [PubMed: 1637076]
- 20.
- Gerlach, M., and Riederer, P. Theories concerning the aetiology and pathogenesis of Parkinson's disease. J. Neural. Transm. (in press), 1998.
- 21.
- Gerlach M , Youdim M B H , Riederer P . Pharmacology of selegiline. Neurology. 1996;47:S137–S145. [PubMed: 8959982]
- 22.
- Birkmayer W , Knoll J , Riederer P , Youdim M B , Hars V , Marton J . Increased life expectancy resulting from addition of l-deprenyl to Madopar treatment in Parkinson's disease: A long-term study. J. Neural Transm. 1985;64:113–127. [PubMed: 3935752]
- 23.
- The Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 1993;328:176–183. [PubMed: 8417384]
- 24.
- Baldessarini R J , Tarsy D . Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu. Rev. Neurosci. 1980;3:23–41. [PubMed: 6106450]
- 25.
- Mena, I. Manganese poisoning. In P. J. Vinkeh and G. W. Broyh (eds.), Handbook of Clinical Neurology. New York: Elsevier, 1977, vol. 21, pp. 217–327.
- 26.
- Gerlach M , Ben-Shachar D , Riederer P , Youdim M B H . Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 1994;63:793–807. [PubMed: 7519659]
- 27.
- Nyberg P , Gottfries C T G , Holmgreen G . et al. Advanced catecholaminergic disturbances in the brain in a case of Wilson's disease. Acta. Neurol. Scand. 1982;65:71–75. [PubMed: 6175159]
- 28.
- Snow B J , Peppard R F , Guttman M . et al. Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig The amyotrophic lateral sclerosis—parkinsonism—dementia complex of Guam. Arch. Neurol. 1990;47:870–874. [PubMed: 2375693]
- 29.
- Duncan M W , Steele J C , Kopin I J , Markey S P . 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cyad flour: An unlikely cause of amyotrophic lateral sclerosis and parkinsonism—dementia of Guam. Neurology. 1990;40:767–772. [PubMed: 2330104]
- 30.
- Young A B , Greenmayre Z , Hollingsworth R . NMDA receptor losses in putamen from patients with Huntington's disease. Science. 1988;241:981–983. [PubMed: 2841762]
- 31.
- DiFiglia M . Excitotoxic injury of the neostriatum: A model for Huntington's disease. Trends Neurosci. 1990;13:286–289. [PubMed: 1695405]
- 32.
- Gerlach M , Gsell W , Kornhuber J . et al. A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia—thalamocortical circuits in Parkinson's syndrome. Brain Res. 1996;741:142–152. [PubMed: 9001716]
- 33.
- Gerlach M , Riederer P . Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man. J. Neural Transm. 1996;103:987–1041. [PubMed: 9013391]
- 34.
- Gerlach, M., and Riederer, P. Pathobiochemische Befunde bei extrapyramidal motorischen Erkrankungen. In G. Huffmann, H.-J. Braune, and K.-H. Henn (eds.), Extrapyramidalmotorische Erkrankungen. Einhorn Presse Verlag, 1994, pp. 49–59.
- PubMedLinks to PubMed
- References - Basic NeurochemistryReferences - Basic Neurochemistry
Your browsing activity is empty.
Activity recording is turned off.
See more...